Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Can J Physiol Pharmacol ; 100(10): 993-1004, 2022 Oct 01.
Article de Anglais | MEDLINE | ID: mdl-35834825

RÉSUMÉ

Besides the health benefits of regular exercise, high-level training-above an optimal level-may have adverse effects. In this study, we investigated the effects of long-term vigorous training and its potentially detrimental structural-functional changes in a small animal athlete's heart model. Thirty-eight 4-month-old male guinea pigs were randomized into sedentary and exercised groups. The latter underwent a 15-week-long endurance-training program. To investigate the effects of the intense long-term exercise, in vivo (echocardiography, electrocardiography), ex vivo, and in vitro (histopathology, patch-clamp) measurements were performed. Following the training protocol, the exercised animals exhibited structural left ventricular enlargement and a significantly higher degree of myocardial fibrosis. Furthermore, resting bradycardia accompanied by elevated heart rate variability occurred, representing increased parasympathetic activity in the exercised hearts. The observed prolonged QTc intervals and increased repolarization variability parameters may raise the risk of electrical instability in exercised animals. Complex arrhythmias did not occur in either group, and there were no differences between the groups in ex vivo or cellular electrophysiological experiments. Accordingly, the high parasympathetic activity may promote impaired repolarization in conscious exercised animals. The detected structural-functional changes share similarities with the human athlete's heart; therefore, this model might be useful for investigations on cardiac remodeling.


Sujet(s)
Cardiomégalie du sportif , Entrainement d'endurance , Animaux , Cochons d'Inde , Mâle , Électrocardiographie , Coeur , Endurance physique , Remodelage ventriculaire
2.
Br J Pharmacol ; 172(6): 1620-32, 2015 Mar.
Article de Anglais | MEDLINE | ID: mdl-24990201

RÉSUMÉ

Although the physiological regulatory function of the gasotransmitter NO (a diatomic free radical) was discovered decades ago, NO is still in the frontline research in biomedicine. NO has been implicated in a variety of physiological and pathological processes; therefore, pharmacological modulation of NO levels in various tissues may have significant therapeutic value. NO is generated by NOS in most of cell types and by non-enzymatic reactions. Measurement of NO is technically difficult due to its rapid chemical reactions with a wide range of molecules, such as, for example, free radicals, metals, thiols, etc. Therefore, there are still several contradictory findings on the role of NO in different biological processes. In this review, we briefly discuss the major techniques suitable for measurement of NO (electron paramagnetic resonance, electrochemistry, fluorometry) and its derivatives in biological samples (nitrite/nitrate, NOS, cGMP, nitrosothiols) and discuss the advantages and disadvantages of each method. We conclude that to obtain a meaningful insight into the role of NO and NO modulator compounds in physiological or pathological processes, concomitant assessment of NO synthesis, NO content, as well as molecular targets and reaction products of NO is recommended.


Sujet(s)
Radicaux libres/métabolisme , Gazotransmetteurs/métabolisme , Monoxyde d'azote/métabolisme , Animaux , Techniques électrochimiques/méthodes , Spectroscopie de résonance de spin électronique/méthodes , Fluorimétrie/méthodes , Radicaux libres/analyse , Gazotransmetteurs/analyse , Humains , Monoxyde d'azote/analyse
3.
Br J Pharmacol ; 153(3): 488-96, 2008 Feb.
Article de Anglais | MEDLINE | ID: mdl-18037908

RÉSUMÉ

BACKGROUND AND PURPOSE: Sensory neuropathy develops in the presence of cardiovascular risk factors (e.g. diabetes, dyslipidemia), but its pathological consequences in the heart are unclear. We have previously shown that systemic sensory chemodenervation by capsaicin leads to impaired myocardial relaxation and diminished cardiac nitric oxide (NO) content. Here we examined the mechanism of diminished NO formation and if it may lead to a reduction of peroxynitrite (ONOO(-))-induced S-nitrosylation of sarcoendoplasmic reticulum Ca(2+)-ATPase (SERCA2a). EXPERIMENTAL APPROACH: Male Wistar rats were treated with capsaicin for 3 days to induce sensory chemodenervation. Seven days later, myocardial function and biochemical parameters were measured. KEY RESULTS: Capsaicin pretreatment significantly increased left ventricular end-diastolic pressure (LVEDP) decreased cardiac NO level, Ca(2+)-dependent NO synthase (NOS) activity, and NOS-3 mRNA. Myocardial superoxide content, xanthine oxidoreductase and NADPH oxidase activities did not change, although superoxide dismutase (SOD) activity increased. Myocardial and serum ONOO(-) concentration and S-nitrosylation of SERCA2a were significantly decreased. CONCLUSIONS AND IMPLICATIONS: Our results show that sensory chemodenervation decreases cardiac NO via decreased expression and activity of Ca(2+)-dependent NOS and increases SOD activity, thereby leading to decreased basal ONOO(-) formation and reduction of S-nitrosylation of SERCA2a, which causes impaired myocardial relaxation characterized by increased left ventricular end-diastolic pressure (LVEDP). This suggests that capsaicin sensitive sensory neurons regulate myocardial relaxation via maintaining basal ONOO(-) formation and SERCA S-nitrosylation.


Sujet(s)
Capsaïcine/pharmacologie , Acide peroxynitreux/métabolisme , Sarcoplasmic Reticulum Calcium-Transporting ATPases/effets des médicaments et des substances chimiques , Fonction ventriculaire gauche/effets des médicaments et des substances chimiques , Animaux , Calcium/métabolisme , Mâle , Myocarde/métabolisme , Neurones afférents/effets des médicaments et des substances chimiques , Neurones afférents/métabolisme , Monoxyde d'azote/métabolisme , Nitric oxide synthase/effets des médicaments et des substances chimiques , Nitric oxide synthase/métabolisme , Nitric oxide synthase type III/effets des médicaments et des substances chimiques , Nitric oxide synthase type III/métabolisme , ARN messager/métabolisme , Rats , Rat Wistar , Sarcoplasmic Reticulum Calcium-Transporting ATPases/métabolisme , Superoxide dismutase/effets des médicaments et des substances chimiques , Superoxide dismutase/métabolisme
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE